Adia Med Statistics
Total Valuation
Adia Med has a market cap or net worth of 14.16 million. The enterprise value is 15.18 million.
| Market Cap | 14.16M |
| Enterprise Value | 15.18M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Adia Med has 94.40 million shares outstanding. The number of shares has increased by 7.41% in one year.
| Current Share Class | 94.40M |
| Shares Outstanding | 94.40M |
| Shares Change (YoY) | +7.41% |
| Shares Change (QoQ) | +70.97% |
| Owned by Insiders (%) | 23.30% |
| Owned by Institutions (%) | n/a |
| Float | 72.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.08 |
| PB Ratio | -37.29 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.32
| Current Ratio | 0.32 |
| Quick Ratio | 0.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.48 |
| Interest Coverage | -5.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 75.90% |
| Weighted Average Cost of Capital (WACC) | -38.08% |
| Revenue Per Employee | 390,753 |
| Profits Per Employee | -92,452 |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +226.75% in the last 52 weeks. The beta is -8.22, so Adia Med's price volatility has been lower than the market average.
| Beta (5Y) | -8.22 |
| 52-Week Price Change | +226.75% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.12 |
| Relative Strength Index (RSI) | 58.60 |
| Average Volume (20 Days) | 11,573 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, Adia Med had revenue of 1.17 million and -277,355 in losses. Loss per share was -0.00.
| Revenue | 1.17M |
| Gross Profit | 491,718 |
| Operating Income | -237,453 |
| Pretax Income | -277,355 |
| Net Income | -277,355 |
| EBITDA | -207,044 |
| EBIT | -237,453 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 128,115 in cash and 993,777 in debt, with a net cash position of -865,662 or -0.01 per share.
| Cash & Cash Equivalents | 128,115 |
| Total Debt | 993,777 |
| Net Cash | -865,662 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -379,781 |
| Book Value Per Share | -0.01 |
| Working Capital | -714,299 |
Cash Flow
In the last 12 months, operating cash flow was -175,765 and capital expenditures -5,496, giving a free cash flow of -181,261.
| Operating Cash Flow | -175,765 |
| Capital Expenditures | -5,496 |
| Depreciation & Amortization | 30,409 |
| Net Borrowing | 214,824 |
| Free Cash Flow | -181,261 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 41.95%, with operating and profit margins of -20.26% and -23.66%.
| Gross Margin | 41.95% |
| Operating Margin | -20.26% |
| Pretax Margin | -23.66% |
| Profit Margin | -23.66% |
| EBITDA Margin | -17.66% |
| EBIT Margin | -20.26% |
| FCF Margin | n/a |
Dividends & Yields
Adia Med does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.41% |
| Shareholder Yield | -7.41% |
| Earnings Yield | -1.96% |
| FCF Yield | -1.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Adia Med has an Altman Z-Score of -25.64 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -25.64 |
| Piotroski F-Score | 1 |